Gene Therapy for Diabetic Macular Edema

Clinical trial NCT05916391 · RECRUITING

Trial details

NCT number: NCT05916391
Sponsor: Frontera Therapeutics
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetic Macular Edema

Start date: 2023-05-19
Primary completion: 2025-05-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.